First Manhattan CO Amicus Therapeutics, Inc. Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $5,821 - $10,308	-657 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$6.63 - $11.16 $4,355 - $7,332	657 New	657 $6,000
Q3 2018 Oct 15, 2018	SELL	$11.6 - $16.54 $58,000 - $82,700	-5,000 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$13.13 - $17.09 $65,650 - $85,450	5,000 New	5,000 $78,000

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.68B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.